[T-786C endothelial nitric oxide gene polymorphism and type 1 diabetic retinopathy in the Algerian population].
Polymorphisme T-786C de l’eNOS dans la rétinopathie du diabète de type 1 chez la population algérienne.
Algerian population
Diabetic retinopathy
Diabète de type 1
Polymorphisme T-786C de l’eNOS
Population algérienne
Rétinopathie diabétique
T-786C eNOS polymorphism
Type 1 diabetes
Journal
Journal francais d'ophtalmologie
ISSN: 1773-0597
Titre abrégé: J Fr Ophtalmol
Pays: France
ID NLM: 7804128
Informations de publication
Date de publication:
Jun 2019
Jun 2019
Historique:
received:
23
08
2018
revised:
18
11
2018
accepted:
19
11
2018
pubmed:
10
4
2019
medline:
7
1
2020
entrez:
10
4
2019
Statut:
ppublish
Résumé
Diabetic retinopathy (DR) results from interactions between genetic and environmental factors. We were interested in the endothelial nitric oxide gene (eNOS), given the involvement of this enzyme in functional alterations in the retinal microvasculature in diabetes. The goal of our study was to assess the association of T-786C endothelial nitric oxide synthase (eNOS) gene polymorphism with diabetic retinopathy in the Algerian population. Our study enrolled 110 patients with and without DR. All subjects were genotyped for the T786C eNOS polymorphism using the PCR-RFLP method. We also investigated the association between this polymorphism and certain clinical and laboratory characteristics of patients with DR. A significant increase in the frequency of the CC genotype is noted in subjects without DR (P=0.03). We also report a significant increase in the frequencies of the TT+TC genotypes in individuals with DR (P=0.03). However, the association between the different genotypes and clinical or laboratory profiles in patients with DR reveals that the NO level is lower in subjects carrying the TT genotype (P=0.039). Our preliminary results suggest that the CC genotype could confer protection from type 1 diabetic retinopathy in the Algerian population, while the T allele seems to confer susceptibility.
Identifiants
pubmed: 30962068
pii: S0181-5512(19)30118-4
doi: 10.1016/j.jfo.2018.11.014
pii:
doi:
Substances chimiques
Glycated Hemoglobin A
0
hemoglobin A1c protein, human
0
NOS3 protein, human
EC 1.14.13.39
Nitric Oxide Synthase Type III
EC 1.14.13.39
Types de publication
Journal Article
Langues
fre
Sous-ensembles de citation
IM
Pagination
579-585Informations de copyright
Copyright © 2019 Elsevier Masson SAS. All rights reserved.